Cargando…
Editorial: Obesity, metabolic phenotypes and COVID-19
Autores principales: | Sanoudou, Despina, Hill, Michael A., Belanger, Matthew J., Arao, Kevin, Mantzoros, Christos S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743503/ https://www.ncbi.nlm.nih.gov/pubmed/35026232 http://dx.doi.org/10.1016/j.metabol.2021.155121 |
Ejemplares similares
-
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023) -
Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action
por: Hill, Michael A., et al.
Publicado: (2021) -
Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
por: Angelidi, Angeliki M., et al.
Publicado: (2020) -
COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021) -
Therapeutic Targets and Personalized Medicine in Cardiac Disease
por: Vafiadaki, Elizabeth, et al.
Publicado: (2023)